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Background: We investigated the association between hemorrhagic stroke and migraine using data from The
Health Improvement Network database.
Findings: We ascertained 1,797 incident cases of intracerebral hemorrhage (ICH) and 1,340 of subarachnoid
hemorrhage (SAH). Density-based sampling was used to select 10,000 controls free from hemorrhagic stroke. Using
unconditional logistic regression models, we calculated the risk of hemorrhagic stroke associated with migraine,
adjusting for age, sex, calendar year, alcohol, body mass index, hypertension, previous cerebrovascular disease, oral
contraceptive use, and health services utilization.
The risk (odds ratio [OR]) of ICH among migraineurs was 1.2 (95% confidence interval [CI] 0.9–1.5), and of SAH was
(1.2, 95% CI 0.9–1.5). The association with ICH was stronger for migraine diagnosed ≥20 years prior to ICH (OR 1.6,
95% CI 1.0–2.4), but not with SAH (OR 1.1, 95% CI 0.6–2.1). In analyses stratified by migraine type and gender, the
OR of ICH in women with migraine with aura was 1.7 (95% CI 0.9–3.4) and the corresponding OR of SAH in women
was 1.2 (95% CI 0.6–2.3).
Conclusion: No clear increased risk of ICH or SAH was observed in migraineurs.
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Migraine is a common disorder [1]. A potential link
between migraine and vascular disease is therefore of
great interest from a scientific and a public health per-
spective. A recent meta-analysis, based on 8 epidemio-
logical studies, concluded that migraine may increase
the risk of hemorrhagic stroke [2]. However, the results
did not allow conclusions to be drawn on hemorrhagic
stroke type [2]. We investigated the relationship between
migraine and hemorrhagic stroke subtypes in the general
population, using data from The Health Improvement
Network (THIN) database [3,4].Methods
The collection of data into THIN was approved by the
South-East Multicentre Research Ethics Committee in
the United Kingdom. The study methodology has been* Correspondence: dgaist@health.sdu.dk
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in any medium, provided the original work is pdescribed in detail in previous publications [3,4]. In
brief, the study cohort comprised all individuals within
the UK medical research database THIN aged 20 to
89 years between January 2000 and December 2008.
Individuals with a diagnosis of ICH or SAH before their
study start date were excluded from the study cohort.
Members in the study cohort were followed from the
start date until the earliest occurrence of one of the
following endpoints: a) hemorrhagic stroke recorded, b)
the patient reached 90 years of age, c) patient death, or
d) the end of the study period (December 2008). For all
patients identified with codes compatible with hemor-
rhagic stroke, free text comments were requested and
the computerized patient profiles were manually re-
viewed. Cases were discarded during this review in the
following instances: the initial diagnostic suspicions were
not confirmed, the event was ischemic rather than
hemorrhagic, the case was prevalent rather than incident
(i.e., not a primary event), the stroke was secondary to
trauma, or the patient experienced intracranial extra-
cerebral hemorrhage other than SAH (e.g., subdural
hematoma). Those not discarded after manual reviewOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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additional data collected from primary care physicians and
described in detail elsewhere, confirmed that 84% of cases
thus identified fulfilled the criteria for the study [3].
Nested case–control analysis
To evaluate the risk of hemorrhagic stroke associated with
migraine, we performed a case–control study nested in
the study cohort. In this analysis, we included as cases all
hemorrhagic strokes, using the date of diagnosis as the
index date. A group of 10,000 controls within THIN was
randomly selected from the pool of eligible person-time
(i.e., using density-based sampling with no replacement)
and was frequency-matched to all cases for sex, age
(±1 year), and calendar year of diagnosis. For all cases and
controls, we ascertained demographic (e.g., age, sex, body
mass index) and lifestyle (e.g., smoking, alcohol intake)
factors, as well as general comorbidities at the index date;
the distribution of these factors among cases and controls
has been previously presented [4].
Migraine diagnosis prior to index date
We ascertained whether subjects suffered from migraine.
Free-text comments on all subjects with Read codes
compatible with a diagnosis of migraine at any time
prior to the index date were requested. Computerized
patient profiles were reviewed by a neurologist with a
special interest in migraine (D Gaist), who was blinded
with regard to case status, i.e. presence of hemorrhagic
stroke. Blinding was achieved by removing records
1 month prior and after the index date for both cases
and controls; furthermore, for cases, all comments that
included codes for haemorrhagic stroke were removed.
A diagnosis of migraine was accepted, unless free text
comments contradicted it, which was the case in 8
women (classified as non-migraineurs). Subjects with
verified migraine diagnosis were subclassified by mi-
graine type, i.e. migraine with aura and migraine without
aura. Only few subjects received codes compatible with
migraine with aura (1 case and 10 controls). A diagnosis
of migraine with aura was thus mainly reached by
reviewing the clinical information included in free text
comments. For patients with migraine, we calculated the
time period between the first diagnosis of migraine and
the index date and classified it as follows: <2, 2–9,
10–19, and ≥20 years.
Statistical analyses
Unconditional regression analyses were run for hemo-
rrhagic stroke and separately for ICH and SAH to esti-
mate odds ratios (ORs), together with 95% confidence
intervals (CIs). ORs presented are compared with not
having migraine. The fully adjusted model included
frequency-matched variables (i.e., age, sex, and calendaryear) and the following covariates: smoking, alcohol,
body mass index, hypertension, previous cerebrovascular
disease (ischaemic stroke or transient ischaemic attack),
oral contraceptive use, and health services utilization
(PCP visits, referrals, and hospitalizations). We also per-
formed analyses stratified by gender and age (≤, >60 years).
All analyses were performed using Stata SE 10.0 (Stata-
Corp, College Station, TX).
Findings
A history of migraine was present in 5.5% subjects with
ICH, 8.1% subjects with SAH, and 5.2% controls (Table 1).
Migraine was associated with a non-significantly increased
risk of hemorrhagic stroke (odds ratio 1.2, 95% CI 1.0-1.4;
P value .078), ICH (OR 1.2, 95% confidence interval [CI]
0.9–1.5), and SAH (OR 1.2, 95% CI 0.9–1.5). In analyses
by subtype of migraine the association remained un-
changed. However, the risk estimate of SAH was not in-
creased in women with migraine with aura (OR 0.9, 95%
CI 0.5-1.7) (Table 1). Analyses of duration since first re-
corded migraine diagnosis revealed that, for migraine, the
association was only present among subjects with a first
diagnosis of this headache ≥20 years prior to ICH (OR 1.6,
95% CI 1.0–2.4) (P value .05), while for SAH no clear pat-
tern was found (Table 1). The association between mi-
graine and ICH was most pronounced for subjects with
migraine with aura aged <60 years at the time of their
hemorrhagic stroke (OR 1.8, 95% CI 0.7-4.4). Male gender
was not associated with increased risk of ICH or SAH
(Table 1). Women, however, were at increased risk of
ICH, particularly if they suffered from migraine with aura
(OR 1.7, 95% CI 0.9–3.4); the risk of SAH in women with
migraine with aura was only slightly raised compared with
non-migraineurs (OR 1.2, 95% CI 0.6–2.3). With the
exception of duration of migraine history (borderline
significant), none of the above mentioned associations
were statistically significant.
Discussion
The major outcome of this study, based on an analysis of
data from more than 3,000 patients with hemorrhagic
stroke is that it does not provide evidence of a clear
increased risk of ICH or SAH in sufferers of migraine.
Although relative risk estimates were slightly to moder-
ately increased for certain subgroups, i.e., the increased
risk of ICH in migraineurs with a long history of migraine,
and in women and subjects under age 60 with migraine
with aura, the results did not reach statistical significance.
A recent meta-analysis reported an overall pooled ad-
justed risk estimate (RR) of hemorrhagic stroke of 1.48
(95% CI 1.16-1.88), which was slightly higher in subjects
with migraine with aura (RR 1.62, 95% CI 0.87-3.03) [2].
Although of a smaller magnitude, the relative risk esti-
mates in our study are similar regarding the association
Table 1 Migraine and risk for intracranial hemorrhage (ICH) and subarachnoidal hemorrhage (SAH)
Number Adjusted OR (95% CI)a
ICH SAH Overall hemorrhagic stroke Controls ICH SAH Overall hemorrhagic stroke
No migraine 1,698 1,231 2,929 9,476 1 (reference) 1 (reference) 1 (reference)
Migraine 99 109 208 524 1.2 (0.9-1.5) 1.2 (0.9-1.5) 1.2 (1.0-1.4)
Migraine without aura 84 97 181 450 1.2 (0.9-1.5) 1.2 (1.0-1-6) 1.2 (1.0-1.4)
Migraine with aura 15 12 27 74 1.2 (0.7-2.2) 0.9 (0.5-1.7) 1.0 (0.7-1.6)
Migraine durationb, years
<2 15 17 32 85 1.1 (0.6-1.9) 1.0 (0.6-1.7) 1.0 (0.7-1.6)
2-9 35 55 90 213 1.1 (0.8-1.6) 1.3 (1.0-1.8) 1.2 (0.9-1.6)
10-19 22 25 47 134 1.1 (0.7-1.8) 1.1 (0.7-1.7) 1.1 (0.8-1.6)
≥20 27 12 39 92 1.6 (1.0-2.4)c 1.1 (0.6-2.1) 1.3 (0.9-2.0)
Age <60 yearsd
Migraine without aura 25 69 94 202 1.2 (0.7-1.9) 1.3 (1.0-1.8) 1.2 (0.9-1.6)
Migraine with aura 6 12 18 36 1.8 (0.7-4.4) 1.3 (0.7-2.6) 1.4 (0.8-2.6)
Age ≥60 yearsd
Migraine without aura 59 28 87 248 1.2 (0.9-1.6) 1.1 (0.7-1.6) 1.1 (0.9-1.4)
Migraine with aura 9 0 9 38 1.0 (0.5-2.1) NAe 0.7 (0.3-1.4)
Men
Migraine without aura 28 19 47 127 1.2 (0.8-1.9) 1.1 (0.7-1.9) 1.1 (0.8-1.6)
Migraine with aura 4 0 4 27 0.7 (0.2-2.3) NAe 0.4 (0.2-1.3)
Women
Migraine without aura 56 78 134 323 1.2 (0.9-1.6) 1.3 (1.0-1.7) 1.2 (1.0-1.5)
Migraine with aura 11 12 23 47 1.7 (0.9-3.4) 1.2 (0.6-2.3) 1.4 (0.8-2.3)
aAdjusted for sex, age, calendar year, smoking, alcohol, body mass index, hypertension, previous cerebrovascular disease, oral contraceptive use, and health
services utilization.
bTime from first recorded migraine diagnosis to index date.
cp value ≤ .05.
dAt index date.
eNot applicable.
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with aura in women. We found that the risk of ICH
increased in subjects with a long history of migraine,
albeit not statistically significantly. A prospective study,
based on data from the Women’s Health Study reported
increased rates of hemorrhagic stroke for women with
migraine towards later years of follow-up, but the risk
increase was only observed in women with active
migraine with aura at baseline [5]. In our study, we
lacked information that would enable reliable identifica-
tion of women with active migraine with aura, a factor
that may have contributed to the lower risk estimates
found in our study compared with Kurth et al.
Although the meta-analysis did not indicate that risk
of hemorrhagic stroke was modified by age, we note that
our findings of higher risk estimates in younger subjects
are in line with those of a recently published large study
[6]. Finally, our finding of a low risk of SAH associated
with migraine is in agreement with the largest of two
studies that addressed this issue [5,7].Our study strengths include reliance on a general prac-
tice based registry, THIN, enabling prospective long-term
follow-up of a large general population in the UK with
continuous registration of health-related events and
information on several potential confounders. The validity
of the hemorrhagic stroke diagnosis in this setting is
high [3].
Our study also has a number of potential limitations. In
spite of the large number of cases of haemorrhagic stroke,
there were few cases with antecedents of migraine with
aura. This limited the statistical power of these analyses.
Furthermore, the diagnosis of migraine was not estab-
lished according to the International Headache Society
criteria [8]. The migraine diagnosis was, however, reached
by general practitioners (GPs) and as such reflects every-
day practice. Not all migraineurs seek medical attention
for their migraine headaches [9]. We find it probable that
migraineurs with milder attacks were less likely to seek
medical attention and may therefore be underrepresented
in our study, which may explain our finding of a rather
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type almost entirely based on free-text comments, since
GPs mostly did not use codes for migraine with aura, even
in cases where they clearly stated this diagnosis and
described aura symptoms in the free-text. This probably
means that some patients with migraine with aura in our
sample have been misclassified as migraine without aura,
due to missing information on aura symptoms in the free-
text. We believe that this source of non-differential
misclassification probably leads to an underestimate of the
association of migraine with aura and hemorrhagic stroke.
We therefore conclude that our study indicates that
migraine, and in particular migraine with aura, may be
associated with an increased risk of ICH, but probably not
SAH. However, given the implications of a link between
migraine and ICH, and the limitations of the present as
well as previous studies, the issue merits further studies.
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